WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 16'9201 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 38'2341 Child (under 5 years) mortality rate: 122

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 4'425  4'200  3'961  3'711  3'465  2'268  1'812  1'154 
Births 81  81  80  78  76  56  70  58 
Surviving infants 81  80  79  77  75  55  68  54 
Pop. less than 5 years 401  384  370  351  331  283  323  230 
Pop. less than 15 years 975  931  892  853  819  842  820  520 
Female 15-49 years 891  866  837  806  773  498  328  237 

Number of reported cases

(Click for retrospective incidence data for Oman)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  111  13  15  1'262  10'630 
Mumps
ChartChart
  112  588  202  163  679  10'443 
Pertussis
ChartChart
  223  120  165  309  165  190  49  1'534 
Polio*
ChartChart
  37 
Rubella
ChartChart
  13 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  48 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Oman)
Vaccine year result method % card seen                                                
BCG 1994  100  FHS   95  99*  99*  99*  99*  99*  98  96  51 
DTP1 1994  100  FHS   95  99*  99*  99*  99*  99  98 
DTP3 1994  98  FHS   95  99*  99*  99  98  98  99*  98  18 
DTP4          99*  98 
IPV1          99*  99* 
HepB_BD          99*  99*  99*  99*  99*  99 
HepB3 1994  98  FHS   95  99*  99*  99  98  98  99* 
Hib3          99*  99*  99  98  98 
JapEnc         
MCV1          99*  99*  99*  99*  99*  99*  98  22 
MCV2          99*  98  99  99*  99*  99* 
MenA         
PCV1          99*  99*  99*  99*  98 
PCV2          99*  99*  99*  99*  99 
PCV3          99*  98  98  99  99* 
Pol3 1994  98  FHS   95  99*  99*  99  99*  99  99*  98  18 
Rota1         
RotaC         
RCV1          99*  99*  99*  99*  99* 
TT2plus          91  60  66  67  71  44  97  39 
PAB          99*  98  98  99  99  99 
VAD1          99*  99*  99*  96  96  99* 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Oman)
BCG
  99  99  99  99  99  98  96  51 
DTP1
  99  99  99  99  99  99  98  41 
DTP3
  99  99  99  98  98  99  98  18 
HepB3
  99  99  99  98  98  99 
HepB_BD
  99  99  99  99  99  99 
Hib3
  99  99  99  98  98 
IPV1
  99  99 
MCV1
  99  99  99  99  99  99  98  22 
MCV2
  99  98  99  99  99  99 
PCV3
  99  98  98  99  99 
Pol3
  99  99  99  99  99  99  98  18 
RCV1
  99  99  99  99  99  99 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 61  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTwP 18 months; Yes
DTwPHibHepB 6 months; Yes
DTwPHibHepBIPV 2, 4 months; Yes
HepB birth; Yes
Influenza Yes adults and children with chronic illness, elderly with chronic illness, health care workers, Haj and other travellers
IPV 9 weeks;
MMR 12, 18 months; above 34 years; Yes
OPV 4, 6, 18 months; 6, 17 years; Yes
Pneumo_conj 2, 4, 13 months; Yes
Rabies Yes high risks (animal bites)
Td 12, 17 years; Yes
TT Yes Pregnant /Wound
Typhoid Yes food handlers
Varicella 12 months; Yes
VitaminA 12, 18 months; Yes also provided to post-partum mothers within 15 days of delivery
YF Yes visiting eligible countries

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2017-2021  2011-2015  2011-2015  2011-2015  2011-2015  2011-2015  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 61  61  61         

System performance

Total Nº districts in country number 61  61  61  61  61  61  61 
Nº districts with DTP3 coverage >=80% number 61  61  61  61  61  61  61 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 61  61  61  61  61  61  61 
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100  100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.